SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-13-000070
Filing Date
2013-07-15
Accepted
2013-07-15 14:19:43
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 f13mar_10qprotectpharmaceuti.htm 10-Q 221362
2 exhibit311.htm EX-31 8180
3 exhibit312.htm EX-31 8041
4 exhibit321.htm EX-32 4014
5 exhibit322.htm EX-32 4143
  Complete submission text file 0001551163-13-000070.txt   1061828

Data Files

Seq Description Document Type Size
6 prtt-20130331.xml EX-101.INS 35136
7 prtt-20130331.xsd EX-101.SCH 8596
8 prtt-20130331_cal.xml EX-101.CAL 15968
9 prtt-20130331_def.xml EX-101.DEF 6118
10 prtt-20130331_lab.xml EX-101.LAB 58961
11 prtt-20130331_pre.xml EX-101.PRE 46117
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 13967840
SIC: 2834 Pharmaceutical Preparations